LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LimmaTech has leveraged a novel technology platform to produce a pipeline of vaccines against multi-resistant bacterial infections that present global health threatsSCHLIEREN, Switzerland (BUSINESS WIRE) LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threate.
Luciole Medical AG Announces the Acquisition of Spiegelberg GmbH & Co KG to Create a Leading Global Brain Monitoring Developer and Provider finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ GlycoEra AG announced today key appointments of biotech industry leaders to its Board of Directors, including Georges Gemayel, Ph.D., as Chair,.
07.05.2021 15:30
Swiss start-ups expand globally at an early stage and and their success draws international investors’ attention to Switzerland as a start-up location.
Dear reader
International orientation is one of the strengths of the Swiss economy. Accordingly, it is a matter of course for Swiss start-ups to expand globally with the help of their first major investment. The number of such start-ups is high: this week alone we reported on five companies that after completion of an early stage round are now addressing global markets. The range is wide, from cybersecurity company Exeon Analytics and catering industry platform Foodetective to rready, which offers B2B SaaS solutions for innovation methods, water management solution provider Droople and bnovate, which enables its customers to search for bacteria in water quickly and automatically.